Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era

By McNamara Mairéad   Lwin Zarnie   Jiang Haiyan   Chung Caroline   Millar Barbara-Ann   Sahgal Arjun   Laperriere Normand   Mason Warren  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression

By McNamara Mairéad   Lwin Zarnie   Jiang Haiyan   Templeton Arnoud   Zadeh Gelareh   Bernstein Mark   Chung Caroline   Millar Barbara-Ann   Laperriere Normand   Mason Warren  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 147-152

Springer Publishing Company

Access to resources Recommend Favorite

Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management

By Shim Hyunsuk   Holder Chad A   Olson Jeffrey J  

CNS Oncology, Vol. 2, Iss. 5, 2013-09 ,pp. : 393-396

Future Medicine

Access to resources Recommend Favorite

Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme

By Baumann Fabian   Bjeljac Miroslava   Kollias Spyros   Baumert Brigitta   Brandner Sebastian   Rousson Valentin   Yonekawa Yasuhiro   Bernays René  

Journal of Neuro-Oncology, Vol. 67, Iss. 1-2, 2004-03 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

Up-front temozolomide in elderly patients with glioblastoma

By Laigle-Donadey Florence   Figarella-Branger Dominique   Chinot Olivier   Taillandier Luc   Cartalat-Carel Stéphanie   Honnorat Jérôme   Kaloshi Gentian   Delattre Jean-Yves   Sanson Marc  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite